Antiviral treatment attenuates hepatitis B virus reactivation after radiotherapy for hepatocellular carcinoma | EASL


  • RSi Communications
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • Antiviral treatment attenuates hepatitis B virus (HBV) reactivation after radiotherapy (RT) for hepatocellular carcinoma (HCC). 

Why this matters

  • There are no convincing data supporting the routine use of preventive therapy against hepatitis B virus (HBV) reactivation in ra...